Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
View ORCID ProfileChiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti, Cathryn M. Lewis
doi: https://doi.org/10.1101/2020.03.31.20048538
Chiara Fabbri
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, United Kingdom
Siegfried Kasper
2Department of Psychiatry and Psychotherapy, Medical University Vienna, Austria
Joseph Zohar
3Department of Psychiatry, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Israel
Daniel Souery
4Laboratoire de Psychologie Medicale, Universitè Libre de Bruxelles and Psy Pluriel, Centre Européen de Psychologie Medicale, Brussels
Stuart Montgomery
5Imperial College School of Medicine, London, UK
Diego Albani
6Laboratory of Biology of Neurodegenerative Disorders, Neuroscience Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Gianluigi Forloni
6Laboratory of Biology of Neurodegenerative Disorders, Neuroscience Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Panagiotis Ferentinos
7Department of Psychiatry, Athens University Medical School, Athens, Greece
Dan Rujescu
8University Clinic for Psychiatry, Psychotherapy and Psychosomatic, Martin-Luther-University Halle-Wittenberg, Germany
Julien Mendlewicz
9Université Libre de Bruxelles
Alessandro Serretti
10Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy
Cathryn M. Lewis
1Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, United Kingdom
Article usage
Posted April 02, 2020.
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti, Cathryn M. Lewis
medRxiv 2020.03.31.20048538; doi: https://doi.org/10.1101/2020.03.31.20048538
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti, Cathryn M. Lewis
medRxiv 2020.03.31.20048538; doi: https://doi.org/10.1101/2020.03.31.20048538
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2971)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12820)
- Forensic Medicine (12)
- Gastroenterology (831)
- Genetic and Genomic Medicine (4624)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4414)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7010)
- Radiology and Imaging (1548)
- Respiratory Medicine (921)
- Rheumatology (445)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)